Posterior leukoencephalopathy syndrome in pediatric patients with kidney disease

Masahiro Ikeda(Shizuoka University), Nahoko Yata, Seiichiro Shishido(Toho University), Hideo Nakai(Dokkyo University), Kohji Mori(Boston Children's Hospital), Kenji Ishikura(Kitasato University), Koichi Kamei(National Center For Child Health and Development), Masataka Honda(Boston Children's Hospital), Hiroshi Hataya(Japanese Society for Dialysis Therapy), Hiroshi Asanuma(Meiji University of Integrative Medicine)
Pediatric Nephrology
January 1, 2002
10.1007/s004670200013
Cited by 6

Related Papers

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
Metformin Prevents Progression of Heart Failure in Dogs
|Circulation|2009|288
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267